需求內(nèi)容在上傳的附件里   [更多]

標(biāo)題： 1、Am Heart J. 2000 Dec;140(6):840-7. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Lucas C1, Johnson W, Hamilton MA, Fonarow GC, Woo MA, Flavell CM, Creaser JA, Stevenson LW. 2、An Updated Portrait of Pathogenesis, Molecular Markers and Signaling Pathways of Hepatocellular Carcinoma 3、Dapoxetine: LY 210448 4、《Analytical Methods》 , 2012 , 4 (12) :4063-4067 5、Curr Opin Allergy Clin Immunol.?2017?Apr;17(2):99-103. doi: 10.1097/ACI.0000000000000346. Asthma?guidelines: the?Global?Initiative for?Asthma?in relation to national guidelines. 6、Kalin P, Mayer JM, Etter JC. Influence of preservatives on the irritation potential of a local anaesthetic on murine cornea. Eur J Pharm Biopharm 1996; 42: 402. 7、Catalytic and Regioselective Ring Expansion of Arylcyclobutanones with Trimethylsilyldiazomethane. Ligand-Dependent Entry to β- Ketosilane or Enolsilane Adducts 8、An Expeditious and Solvent-Free Synthesis of Substituted Pyrroles Using Sulfated Anatase-Titania as a Solid Acid Catalyst 9、Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials 10、Synlett, 1998 , # 9 p. 1022 - 1024 Evelyn 11、Organic and Biomolecular Chemistry, 2016 , vol. 14, # 13 p. 3459 - 3468 12、SCOPE (Study of Cognition and Prognosis in the Elderly) and ACCESS ( evaluation of acute candesartan cilexetil in stroke survivors) Trials Expert Opinion on Pharmacotherapy 13、STROKE REDUCTION WITH CANDESARTAN BASED THERAPY IN THE SCOPE STUDY - OUTCOMES IN PATIENTS BY BASELINE CHARACTERISTICS 14、Study on COgnition and Prognosis in the Elderly (SCOPE) 要求：將符合標(biāo)題的PDF文件打包上傳，根據(jù)投稿時(shí)間定稿，先到先得   [更多]

需要湖南醫(yī)療的公示價(jià)格目錄,全套   [更多]

任務(wù)描述：根據(jù)文獻(xiàn)題目等相關(guān)信息，在網(wǎng)上下載準(zhǔn)確的文獻(xiàn)，每篇文獻(xiàn)1元。文獻(xiàn)數(shù)量有266篇，均是中文文獻(xiàn)，需要找兩個(gè)威客來(lái)下載文獻(xiàn)，每人下載133篇。 要求：1.下載文件類(lèi)型為PDF，內(nèi)容完整，文件名稱(chēng)要包含文獻(xiàn)題目。 2.投稿的用戶自己有下載文獻(xiàn)的資源或途徑，我方不提供文獻(xiàn)庫(kù)的賬號(hào)等。 3.完成時(shí)間：2015年8月24日之前。4.一旦接受此項(xiàng)任務(wù)，不得中途退出。   [更多]

網(wǎng)址：https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_journal_home_pr?p_JournalID=2&p_VolumeID=43 求2018年第一期和第二期的Drugs of the Future的全部14篇文獻(xiàn)   [更多]

文獻(xiàn)名稱(chēng): 1、 Premedication with?Intravenous Ibuprofen?Improves Recovery Characteristics and Stress Response in Adults Undergoing Laparoscopic Cholecystectomy: A Randomized Controlled Trial. Le V, Kurnutala L, SchianodiCola J, Ahmed K, Yarmush J, Daniel Eloy J, Shapiro M, Haile M, Bekker A. Pain Med. 2016 Feb 18. pii: pnv113. [Epub ahead of print] 2、 A multicenter, randomized, double-blind placebo-controlled, single dose trial of the safety and efficacy of?intravenous ibuprofen?for treatment of pain in pediatric patients undergoing tonsillectomy. Moss JR, Watcha MF, Bendel LP, McCarthy DL, Witham SL, Glover CD. Paediatr Anaesth. 2014 May;24(5):483-9. doi: 10.1111/pan.12381. Epub 2014 Mar 20. 3、 Early?intravenous ibuprofen?decreases narcotic requirement and length of stay after traumatic rib fracture. Bayouth L, Safcsak K, Cheatham ML, Smith CP, Birrer KL, Promes JT. Am Surg. 2013 Nov;79(11):1207-12. 4、 Impact of oral versus?intravenous ibuprofen?on neurodevelopmental outcome: a randomized controlled parallel study. 5、 Ahn BO, Dong HK, Cho H, Kang KK, Park BS, Na KH, et al. Four-week Repeated Dose Toxicity Study of Recombinant Human Basic Fibroblast Growth Factor by Subcutaneous Administration in Rats. Toxicological Research. 1999;15. 6、 Dong HK, Cho H, Kang KK, Ahn BO, Kim WB. Acute Toxicity Study on Recombinant Human Basic Fibroblast Growth Factor in Rats and Dogs. Toxicological Research. 1999;15. 7、 Meduri A, Aragona P, Grenga PL, Roszkowska AM. Effect of basic fibroblast growth factor on corneal epithelial healing after photorefractive keratectomy. Journal of refractive surgery (Thorofare, NJ : 1995). 2012;28(3):220-3. Eras Z, Gokmen T, Erdeve O, Ozyurt BM, Saridas B, Dilmen U. Am J Perinatol. 2013 Nov;30(10):857-62. doi: 10.1055/s-0033-1333667. Epub 2013 Jan 28. 8、 Intravenous ibuprofen?for postoperative pain. Kroll PB. Pain Manag. 2012 Jan;2(1):47-54. doi: 10.2217/pmt.11.68. 9、 A multicenter, randomized, double-blind,   [更多]

①文獻(xiàn)和網(wǎng)站來(lái)源必須權(quán)威、專(zhuān)業(yè)，盡量找外文或官網(wǎng)的文獻(xiàn)或報(bào)道，不能是百度百科等； ②簡(jiǎn)要概述的語(yǔ)句具有邏輯性和連貫性。 ③由于藥物本身存在信息不全或難找到信息源，以及藥物概述質(zhì)量不定（如翻譯質(zhì)量不定等）的情況，賞金酌情給出，請(qǐng)諒解。 ④單價(jià)8元/條，質(zhì)量偏低需折價(jià)計(jì)算。 2021-04-02交稿：13個(gè)合格，11個(gè)內(nèi)容偏少，13*8+11*4=148   [更多]

具體需求在附件里   [更多]

1、小兒復(fù)方氨基酸注射液(18AA-Ⅱ)，最新說(shuō)明書(shū)，要求2020年-2023年任一年即可，企業(yè)不限，越新越好。2、復(fù)方電解質(zhì)醋酸鈉注射液，要求：北京費(fèi)森尤斯卡比醫(yī)藥有限公司，國(guó)藥準(zhǔn)字H20233023，2023年。3、國(guó)藥準(zhǔn)字H20233646，ω-3甘油三酯(2%)中長(zhǎng)鏈脂肪乳氨基酸(16)葡萄糖(36%)注射液，廠家：四川科倫藥業(yè)股份有限公司，要求2023年。4、藥品名稱(chēng)：恩那度司他片，要求廠家：深圳信立泰藥業(yè)股份有限公司，2023年。5、鹽酸精氨酸注射液，要求廠家：廣東雷允上藥業(yè)有限公司，2020年或2021年說(shuō)明書(shū)。6、注射用青霉素鈉，廠家要：華北制藥集團(tuán)先泰藥業(yè)有限公司，要求查找過(guò)一致性評(píng)價(jià)的說(shuō)明書(shū)。7、復(fù)方電解質(zhì)注射液(Ⅴ) 英文名稱(chēng)：Multi-Electrolyte Injection，要求：持證商：B Braun 。Medical Inc要求：附件說(shuō)明書(shū)，圖片或者pdf。過(guò)一致性評(píng)價(jià)的說(shuō)明書(shū)需要有過(guò)評(píng)標(biāo)記。   [更多]

羥基脲原料質(zhì)量信息   [更多]